Thomas Flaten
Stock Analyst at Lake Street
(0.89)
# 3,557
Out of 4,818 analysts
38
Total ratings
27.03%
Success rate
-17.93%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCX OncoCyte | Initiates: Buy | $5 | $3.01 | +66.11% | 5 | Mar 28, 2025 | |
| OPTN OptiNose | Downgrades: Hold | $17 → $9 | $9.18 | -1.96% | 5 | Mar 20, 2025 | |
| CKPT Checkpoint Therapeutics | Downgrades: Hold | $7 → $4.1 | $4.05 | +1.36% | 5 | Mar 10, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $2.83 | +183.19% | 2 | Mar 7, 2025 | |
| EVAX Evaxion Biotech | Maintains: Buy | $35 → $6 | $1.47 | +308.16% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $3.69 | +144.23% | 2 | Jan 8, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $34 → $40 | $21.36 | +87.31% | 5 | Nov 5, 2024 | |
| DERM Journey Medical | Initiates: Buy | $9 | $7.44 | +20.97% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.61 | +392.37% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.44 | +350.82% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $24.39 | +2.50% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $3.67 | +39,137.06% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $3.94 | +103.05% | 1 | Jul 7, 2022 |
OncoCyte
Mar 28, 2025
Initiates: Buy
Price Target: $5
Current: $3.01
Upside: +66.11%
OptiNose
Mar 20, 2025
Downgrades: Hold
Price Target: $17 → $9
Current: $9.18
Upside: -1.96%
Checkpoint Therapeutics
Mar 10, 2025
Downgrades: Hold
Price Target: $7 → $4.1
Current: $4.05
Upside: +1.36%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.83
Upside: +183.19%
Evaxion Biotech
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $1.47
Upside: +308.16%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.69
Upside: +144.23%
Castle Biosciences
Nov 5, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $21.36
Upside: +87.31%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $7.44
Upside: +20.97%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.61
Upside: +392.37%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.44
Upside: +350.82%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $24.39
Upside: +2.50%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $3.67
Upside: +39,137.06%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $3.94
Upside: +103.05%